Fish oil (medical use)
| Clinical data | |
|---|---|
| Trade names | Omegaven |
| Other names | Fish oil triglycerides |
| AHFS/Drugs.com | Professional Drug Facts |
| License data | |
| Pregnancy category |
|
| Dependence liability | Intravenous |
| Drug class | Intravenous nutritional products |
| ATC code |
|
| Legal status | |
| Legal status | |
Fish oil, sold under the brand name Omegaven, is a fatty acid emulsion.[2] It is used for total parenteral nutrition (feeding directly into a venous catheter), e.g. in short bowel syndrome.[2] It is rich in omega-3 fatty acids.[2]
Fish oil triglycerides was approved for use in the United States in July 2018,[3] and is available to people on the US market by prescription effective November 2018.[4]
In 2021, it was the 283rd most commonly prescribed medication in the United States, with more than 700,000 prescriptions.[5][6]
- ^ "Fat emulsion Use During Pregnancy". Drugs.com. 4 May 2020. Retrieved 12 May 2020.
- ^ a b c d "Omegaven- fish oil injection, emulsion". DailyMed. 6 August 2018. Retrieved 13 May 2020.
- ^ "Drug Approval Package: Omegaven (fish oil triglycerides)". U.S. Food and Drug Administration (FDA). 24 August 2018. Retrieved 12 May 2020.
- ^ Research, Center for Drug Evaluation and. "Investigational New Drug (IND) Application - How to request Omegaven for Expanded Access Use". www.fda.gov. Archived from the original on 17 September 2014. Retrieved 15 February 2019.
- ^ "The Top 300 of 2021". ClinCalc. Archived from the original on 15 January 2024. Retrieved 14 January 2024.
- ^ "Fish Oil - Drug Usage Statistics". ClinCalc. Retrieved 14 January 2024.